Lazard Asset Management LLC Amicus Therapeutics, Inc. Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 8,506 shares of FOLD stock, worth $84,124. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,506
Previous 150 5570.67%
Holding current value
$84,124
Previous $1,000 8900.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$9.55 - $12.09 $79,799 - $101,024
8,356 Added 5570.67%
8,506 $90,000
Q2 2024

Aug 14, 2024
SELL
$9.04 - $11.75 $63,325 - $82,308
-7,005 Reduced 97.9%
150 $1,000
Q1 2024

May 14, 2024
SELL
$11.43 - $14.24 $49,286 - $61,402
-4,312 Reduced 37.6%
7,155 $83,000
Q4 2023

Feb 14, 2024
BUY
$9.97 - $14.52 $4,436 - $6,461
445 Added 4.04%
11,467 $162,000
Q3 2023

Nov 14, 2023
BUY
$11.78 - $13.86 $62,693 - $73,762
5,322 Added 93.37%
11,022 $134,000
Q2 2023

Aug 14, 2023
SELL
$10.72 - $13.3 $103,769 - $128,744
-9,680 Reduced 62.94%
5,700 $71,000
Q1 2023

May 15, 2023
BUY
$10.91 - $13.54 $12,950 - $16,071
1,187 Added 8.36%
15,380 $170,000
Q4 2022

Feb 14, 2023
BUY
$9.89 - $12.7 $43,080 - $55,321
4,356 Added 44.28%
14,193 $173,000
Q2 2022

Aug 09, 2022
BUY
$6.23 - $11.12 $24,801 - $44,268
3,981 Added 67.98%
9,837 $105,000
Q4 2021

Feb 09, 2022
SELL
$9.82 - $12.44 $1.11 Million - $1.4 Million
-112,559 Reduced 95.05%
5,856 $67,000
Q3 2021

Nov 15, 2021
BUY
$8.74 - $11.84 $1.03 Million - $1.4 Million
118,415 New
118,415 $1.13 Million
Q2 2021

Aug 12, 2021
SELL
$8.71 - $10.72 $49,272 - $60,643
-5,657 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$9.2 - $23.86 $25,419 - $65,925
2,763 Added 95.47%
5,657 $55,000
Q3 2020

Nov 13, 2020
SELL
$12.89 - $15.89 $23,627 - $29,126
-1,833 Reduced 38.78%
2,894 $40,000
Q2 2020

Aug 13, 2020
SELL
$8.86 - $15.69 $28,874 - $51,133
-3,259 Reduced 40.81%
4,727 $71,000
Q1 2020

May 14, 2020
BUY
$6.63 - $11.16 $28,760 - $48,412
4,338 Added 118.91%
7,986 $73,000
Q4 2019

Feb 13, 2020
BUY
$7.48 - $10.75 $20,487 - $29,444
2,739 Added 301.32%
3,648 $35,000
Q3 2019

Nov 14, 2019
BUY
$8.02 - $13.25 $7,290 - $12,044
909 New
909 $7,000
Q2 2019

Aug 14, 2019
SELL
$10.96 - $14.4 $68,423 - $89,899
-6,243 Closed
0 $0
Q1 2019

May 13, 2019
SELL
$10.04 - $13.92 $91,163 - $126,393
-9,080 Reduced 59.26%
6,243 $84,000
Q4 2018

Feb 13, 2019
SELL
$8.38 - $13.44 $628,768 - $1.01 Million
-75,032 Reduced 83.04%
15,323 $146,000
Q2 2015

Jul 08, 2019
BUY
N/A
90,355
90,355 $1.28 Million

Others Institutions Holding FOLD

# of Institutions
313
Shares Held
314M
Call Options Held
516K
Put Options Held
833K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.77B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email